Skin Aging
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women will be included; 40-65 years old; with skin phototypes II, III and IV on the Fitzpatrick scale and signs of aging III and IV in Glogau scale.
Exclusion criteria
Exclusion criteria: Will be excluded from the study male patients; women under the age of 40 and over 65; with thyroid changes (hyperthyroidism or hypothyroidism) and who are not taking the treatment or taking the medication for less than 1 year; who have received facial fillers in the last 12 months; who are performing some facial aesthetic procedure; that they are taking retinoic acid or any vitamin A derivative (tretinoin or isotretinoin, topical or oral); who are using cosmetics or medications that may increase skin photosensitivity; that they present some skin pathology, such as acne, psoriasis, vitiligo, etc .; who presents big laterality of skin aging; professional drivers; who have undergone bariatric surgery or who are under strict diet; that they are making use of some type of supplement (topic or oral) for improvement of the skin conditions; in the period of pregnancy and / or lactation; patients who are not assiduous in the sessions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: As primary endpoint it is expected to find reduction at the thickness and depth of wrinkles at periocular area measured by the equipment Visioface RD - eletronic Ck. The measurements will be performed before and after 10 phototherapy sessions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: As secondary endpoint it is expected to find better skin viscoelasticity through the periocular Cutometer equipment - dual MPA 580 (CK Electronic).The measurements will be performed before and after 10 phototherapy sessions. ;Expected outcome 3: As secondary endpoint it is expected to find better skin moisturization at the periocular region measured trough Corneometer - CM 825 (CK Eletronic). The measurements will be performed before and after 10 phototherapy sessions. ;Expected outcome 4: As secondary endpoint it is expected to find smaller transepidermal water loss is assessed with the Tewameter - 300 TM (CK Electronic). The measurements will be performed before and after 10 phototherapy sessions. ;Expected outcome 5: As secondary endpoint it is expected to find better quality of life and self assessment of the patients measured by questionnaires. The adapted version of the questionnaire of quality of life of patients with dermatological diseases and the adapted version of the questionnaire of quality of life of Melasma patients will be used for quality of life evaluation. The self assessment will be done by the rhytidectomy outcome evaluation questionnaire. All questionnaires will be performed before and after the 10 sessions treatment. The measurements will be performed before and after 10 phototherapy sessions. The measurements will be performed before and after 10 phototherapy sessions. | — |
Countries
Brazil
Contacts
Universidade Nove de Julho